Welcome to UBIFRANCE, the french Trade Commission Portal

News in your activities



PRESS RELEASE - 17-oct.-2016 18:06:52

  Press release October 2016   LASELEC CELEBRATES 15 YEAR ANNIVERSARY WITH ELECTRICAL HARNESS AUTOMATION AT NBAA 2016 Founded in 2001, LASELEC designs and manufactures cutting-edge electrical wire processing equipment: UV laser wire markers, laser wire strippers, interactive harness assembly boards, harness braiding machines. This wide range of products demonstrates the company’s willingness for continuous innovation and leadership in the latest trends in aircraft electrical harness manufacturing – And that latest trend is AUTOMATION ! LASELEC will present its automatic solutions in a special presentation at the NBAA 2016 show:   The RAPIDSHARE Automated Wire Processing Line Prior to RapidShare being launched, the first step in the manufacturing process of an aerospace electrical harness started with the marking and cutting of wires. Next the operator had to manually group the batch of wires. Then the operator would label and sort those batches for production processing before sending them to the shop floor for assembly on a form board. Laselec has initiated the new trend in the harness manufacturing with GE Aviation being the first customer to experience an unprecedented level of automation. RapidShare is a solution designed to automate wire processing production.   The RapidShare robot arm, attached to the ULYS Modena laser wire marker, is able to perform automatic tasks such as:   labelling, stripping, crimping, bundling and kitting processes.   The operator is now free to handle multiple tasks/machines instead of operating a single marking machine for an entire shift. RapidShare’s compatibility with the ULYS Modena line of laser wire markers has allowed companies, such as Airbus Group which owns several Laselec’s markers, to   upgrade to the automated production system that has increased their competitiveness. Also on display during NBAA 2016, is the ALL NEW Sylade 7 laser wire stripper . The Laselec patented laser cutting technology is a safe solution for jacket stripping of MIL-SPEC cables. This all new version features a trigger sensor, auto-select strip lengths and a faster cutting process. With SYLADE, jacket stripping becomes SAFE, QUICK and FUN! The EasyWiring interactive harness form board will be on display at NBAA 2016 as well.   This digital wiring harness board replaces the traditional wooden boards. The embedded software provides a step by step guided assembly processes to increase manufacturing productivity and reduce cabling errors. In addition to Rapidshare, LASELEC has also launched its new over-braiding machine. The BRAIDO series provides complete automation for the production of overbraiding. The software, developed by LASELEC, offers many functions allowing a significant increase in productivity. BRAIDO customers especially appreciate the simplicity of the braiding operation as well as the machine’s impressive speed and low noise reduction. By networking different BRAIDO machines the operator can begin the work on one machine and transfer the job to another machine and still maintain the continuity of the traceability data. LINK BELOW FOR COMPLETE PRESS RELEASE. For further information: Frederick Viaut, Sales Manager Richard Hinegardner, Sales Representative Phone: 817-460-7830          


PRESS - 03-oct.-2016 21:40:13

MEDSTARTUP PARTNERING DAY 2016 Details Start: October 27, 2016 End: October 27, 2016 Event Category: Partner Event Website: Organizer: Galien Foundation & Business France Phone: 212 400 2168 Website : Sponsors: Medidata & BIO Registration: Free for Early Birds Venue: Alexandria Center for Life Sciences, 450 E 29th St, New York, NY 10016 Business France & The Galien Foundation are pleased to invite you to the Medstartup Partnering Day to: NETWORK with +250 Leaders in the EHealth/Pharma/Medtech industries SOURCE INNOVATION Meet with +50 innovative French Health Tech companies EXPAND Identify strategic partners to access to the European market       This year we will count with the presence of Bernard Poussot, Director, Roche Holding, Former President & CEO, Wyeth -   Joel Marcus, Founder & CEO, Alexandria Real Estate Equities. - Roch DOLIVEUX - Honorary CEO, UCB -Mikael DOLSTEN - Global R&D President, Pfizer -Jean-Pierre GARNIER – Former CEO, GSK -Franz HUMER - Former CEO, Roche -François MAISONROUGE - Senior Managing Director, EvercorePartners -Paul STOFFELS - Chief Scientific Officer, Johnson and Johnson -Elias ZERHOUNI - Global R&D President, Sanofi Key Figures & Facts: +20 New EU-US collaborations per year +65% of C-Levels +550 BtoB Meetings +250  Leaders Every year, MedStartUp Program organized by the Galien Foundation & Business France encourages and rewards transatlantic partnerships in the Healthcare industries. The MedstartUp will bring together:   55 highly innovative French companies in the healthcare industry and 250 American leaders in the Pharma/MedTech /Digital Health industries. For further information, visit our website

TK’Blue, rating transport to improve its economic and societal performance

PRESS RELEASE - 23-sept.-2016 22:09:36

  Founded in 2011, TK’Blue is an accreditation and rating agency specializing in goods transport. It takes the form of a service platform for the sector’s various players – carriers, shippers and freight forwarders – covering all modes of transport: road, rail, sea, river and air. In line with EU directives, it allows organizations to evaluate and manage the societal and environmental impact of their transport operations, taking into account all the negative externalities engendered (greenhouse gases/CO 2 , particles, pollution, noise, congestion, accidents, etc.). TK’Blue accredits carriers based on an online questionnaire, awarding them a TK’T score in the process. The score is directly proportional to the quality of their equipment, their facilities and the training they offer their drivers. This accreditation is free of charge for road haulage firms. The analytical criteria used are tailored to the specificities of each mode of transport and were selected and validated by experts, scientists and European transport professionals. The TK’T score is the first to offer shippers an objective assessment of the performance they can expect from the transport fleets of their service providers, allowing them to identify any improvement areas to work on with the latter. Shippers can also take advantage of detailed and constantly updated environmental and societal information regarding their transport operations. This allows them to perfectly meet the latest reporting requirements in terms of greenhouse gas emissions and their CSR commitment. TK’Blue’s current clients are major shippers (Carrefour, Procter&Gamble, Sanofi, Castorama, METRO, Adisseo, BIC, Bekaert, Schneider Electric, Séphora, etc.) and thousands of carriers in Europe Philippe Mangeard, President and Founder of the agency, underlined its ambition to “Improve the economic and environmental performance of the transport services provided to shippers by raising the profile of carriers that offer the best equipment and personnel, thereby going beyond a rationale that focuses solely on the price of transport and boosting the reliability, security and punctuality of operations”. Bolstered by its success in France, the TK’Blue agency is now keen to place its innovative service platform at the disposal of international clients, particularly in Germany, the United Kingdom and the United States. It is currently seeking partners and customers who will act as early adopters in these countries.     About TK’Blue: TK’Blue is a non-financial transport rating agency that takes the form of a service platform. It evaluates, rates and values the environmental performance of every stakeholder in the chain – be they carriers, freight forwarders or shippers – in accordance with the legal and regulatory requirements relating to CO 2 emissions and CSR, at both national and European level. Its cross-European governance, which includes more than 60 individuals representing the logistics chain’s various stakeholders, experts and operators, enhances its legitimacy, as well as its credibility, evolution, fitness for purpose and independence in the long term.   TK’Blue and environmental analysis specialists Vigeo Eiris signed a methodological partnership in 2016. For more information, visit:   For more information:     TK’Blue Agency   Contacts:   In English: Karim Nemouchi – - +33 7 68 64 16 35 In German: François Mebs – - +33 6 78 60 37 42  

French Tech Ticket - Season 2: Submit Your Startup Project Today!

PRESS - 27-juil.-2016 16:07:28

  French Tech Ticket - season 2: Submit your startup project today! Apply to the global competition and get a chance to grow your startup in a booming ecosystem! 70 selected startups will be awarded a full package of benefits including a 45,000 Euros prize money, 1-year incubation, a dedicated masterclass programme… and much more! Your startup project is in BioTech, Mobile/Web, Big Data, FinTech, Social Innovation or any other industry? With over 40 partner incubators all over France to choose from, you’ll find the right one to lead you to success! The competition is open to entrepreneurs from all over the world and there’s only one month left to apply! Check out the French Tech Ticket website for more information and apply online before August 24 th !  

PRESS: Defymed Receives Support from JDRF to Fight Type 1 Diabetes

PRESS - 13-juil.-2016 00:41:48

Defymed Receives Support from JDRF to Fight Type 1 Diabetes JDRF will contribute up to $500,000 in funds to finance preclinical studies on the MAILPAN ® bioartificial pancreas NEW YORK, July XX 2016 – Defymed, a French biotechnology company specializing in the development of bioartificial organs today announced a partnership with JDRF, the leading global organization funding type 1diabetes (T1D) research. This new investment gives Defymed the opportunity to advance its pre-clinical studies in order to demonstrate the MAILPAN ® immunoprotection properties, safety and function. This is an essential step before beginning the clinical trials on humans. " JDRF is known as the number-one worldwide public foundation fighting type 1 diabetes. We are more than honored to be working with them for the necessary pre-clinical tests before starting the MAILPAN® clinical phase ," explains Dr. Séverine Sigrist, CEO of Defymed. " More than financial support, JRDF brings to us considerable visibility within the U.S. market and also provides strategic support in regards to finding a solution to encapsulating insulin-secreting cells to derive the benefits offered by this therapy to patients suffering from type 1 diabetes." With this support, Defymed will move significantly forward with clinical trials in humans. This new project, scheduled to take up to 24 months, will be conducted simultaneously as other research and development programs currently in progress at Defymed. It will allow Defymed to test the MAILPAN® bioartificial pancreas designed for type 1 diabetics through the preclinical phase in order to: - Strengthen the results on MAILPAN ® ’s immunoprotection properties in combination with insulin-secreting cells. - Confirm collected data on the MAILPAN ®’s functionality and safety , also in combination with insulin-secreting cells. MAILPAN® , a disruptive technology for a better life Almost 25 million people around the world suffer from type 1 diabetes. MAILPAN®, an implantable bioartificial pancreas, is a serious alternative to existing treatments. This medical device is designed to restore normal and continuous insulin production in diabetic patients. Implanted in the abdomen, it takes the shape of a pouch containing insulin-secreting cells. The potential of MAILPAN® will bring numerous advantages in comparison to current treatments (e.g., no anti-rejection drugs in case of pancreatic transplants, absence of multiple insulin injections per day). The bioartificial pancreas’ underlying principle’ is to encapsulate insulin-secreting cells between membranes impermeable to the immune system, but permeable enough for oxygen, nutrients, glucose and insulin. A bioartificial pancreas must fulfill three prerequisite functions: to protect transplanted cells from the patient immune system, to protect the patient from transplanted cells, and to maximize the function of the transplanted cells. The goal of the project is to ensure the function and safety of the medical device, utilizing Defymed’s expertise in the biomaterial and cell transplant , as well as preclinical validation and non-invasive imaging technologies. This strategic step for Defymed confirms the therapeutic interest of the MAILPAN® and will generate preclinical data that is absolutely necessary to build strong regulatory documentation for the MAILPAN® , associated with insulin-secreting cells, which will be necessary to bring it to clinical trials in humans. "JDRF is excited to announce its support of Defymed as it seeks preclinical validation of its MAILPAN® device, a project which is well aligned with JDRF’s Beta Cell Replacement strategy," said Derek Rapp, JDRF president and CEO. "By funding this type of research, we firmly believe we are moving one step closer to our goal of creating a world without type 1 diabetes. Major challenges for Alsatian biotech JRDF support appears as a testament of confidence and represents an important opportunity for Defymed to make significant strides in the biotech world. It will indeed bring more visibility and awareness to French biotech on an international platform. From a strategic standpoint, this financial support will also allow Defymed to pursue its development in Europe but also to prepare its entry in its new target market, the U.S. Defymed has also become a member of the encapsulation consortium, a key JDRF initiative. Its goal is to accelerate the development of a bioartificial pancreas for individuals living with type 1 diabetes. For the complete press release, click the link below    

FRENCH ART OF FURNISHING: 6 companies to keep an eye on at M&O Americas

Geoffroy THAUMIN - 20-avr.-2016 20:35:39

For the very first time, the GEM –the export department of the French furniture industry association– is bringing together six major French furniture players at Maison & Objet Americas. A first step in the US for the GEM, this rendez-vous with French furniture will be followed by many more! The FRENCH ART OF FURNISHING Pavilion will be located booths #1312-1417.  Among the exhibitors: Gautier and its extensive range of stylish and contemporary furniture, but also Maison Montaigne Paris, who represents more than 16 European brands in their Miami showroom. Visitors will also be introduced to Fermob, Sifas and Vlaemynck. Renowned internationally for their premium and luxury outdoors furniture, their designs are created with grace and manufactured to last. Last but not least, Objet de Curiosité will showcase their many wonders, from decorative shells to steampunk lights and from exotic butterflies to mysterious stones. Already successful in France, and for some of them in the US, where their craftsmanship is recognized in niche or mainstream markets, our exhibitors are excited to present their latest designs during the show. For more information about the Pavilion or our exhibitors, please read our online catalogue .

Strong U.S.-France Relationship Good for Global Economy

Muriel Pénicaud - 18-avr.-2016 20:44:10

As the world continues to recover from the Great Recession and further unites against global threats to our security and the safety of our citizens, the importance of growing and bolstering the global economy is an increasing priority for many nations. It is a logical conclusion for those who recognize that an invigorated economic foundation is vital and is in the best interest of the entire planet. In that light, France has made it a top priority to create an environment that is welcoming to business—whether startups or established, French created or multinational. To shine a spotlight on the latter, Business France recently released its “ 2015 Annual Report: Foreign Investment in France—The International Development of the French Economy. “ Findings from the report demonstrate that the efforts we are making in France to attract foreign business are working. For example, in 2015 we saw a 27 percent increase in jobs generated by foreign investment over 2014 figures, and 53 different countries invested in 2015, up from 47 in 2014. Broadly, we have 19 new investment decisions per week. As a reminder, 20,000 foreign companies are operating in France and employing almost 2 million people. Read the full editorial and learn more about France’s appeal on the Huffington Post’s website

About us
Henri Baissas: "Welcome to Business France North America! We assist French companies who want to export in North America, and North American companies who want to invest in France. Our team has both the knowledge and the experience to facilitate BtoB trade relations between the three countries. With offices and branches in New York, Boston, Toronto, Montréal, Atlanta, Detroit, Chicago, Houston, Vancouver, and San Francisco, Business France North America is present from coast to coast. Close to 100 Business France experts focus on the following sectors: - Agrotech (wine, spirits, beer, beverages, food, and equipments for the agricultural and food industry) - Industry & clean tech (public works & transportation, energy & clean techs, industry) - Art de vivre & healthcare (biotechnologies, cosmetics, healthcare, fashion, luxury, culture, sport, home decor and tourism) - Tech & services (new technologies, retail and services, innovation


    You Buy France 


    Rail industry 







Press area & Media Gallery
List of last comments